Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

Australia: THC completes Queensland R&D and cultivation facility

The Hydroponics Company has successfully completed stage 1 of its R&D facility and growing capability in Queensland. Since October 2017, THC has increased the investment in, and focus upon, the development of the Queensland site.

The site has been developed to allow for increasing demand for high quality medicinal cannabis products in both local and export markets. Stage 1 of the development includes greenhouses for indoor cultivation and growth of medicinal cannabis, a drying and shredding facility for the initial processing of the dried plants, and an extraction laboratory for the processing of crude extract from the shredded plants.

The site will also provide an onsite laboratory for development of new strains, as well as testing and quality control of harvested products. The current site, when fully optimized, will be scalable to meet the demands of a growing market.

THC plans to vertically integrate along the industry value chain by producing a high quality, processed product that will differentiate THC from companies focused solely upon the production of medicinal cannabis as an agricultural commodity. Stage 2 of the Strategic Growth plan for THC is to further process the raw material (dry bud) into higher value medicinal cannabis oils for use in both Australian and international patients. These products will be provided to approved Australian patients through the National Access Cannabis clinics in Australia as a branded product, along with other premium products from international partners. Conversations have commenced with National Access Cannabis, Canada to supply high quality Canndeo products to supplement NAC’s existing product portfolio. As at 31 August 2017, NAC Canada had in excess of 8,500 members.

David Radford of THC states: "The Board recognises the significant contribution of the Queensland team to the growth of the business. This small team has contributed significantly to the development and submission of the licence applications to the ODC, whilst managing the build out. We look forward to being granted the manufacturing licence and final approvals in order to commence the growing and manufacturing program of high quality medicinal products”.

For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia

Publication date: 2/21/2018



Other news in this sector:

6/21/2018 US (NV): Cannabis grower expands cultivation by 40%
6/21/2018 CAN (QC): First plants in at 250,000 sq.ft. MMJ greenhouse
6/20/2018 CAN (QC): MYM cuts ribbon for 1.5 million sq.ft. MMJ facility
6/20/2018 "Our industry has been going broke"
6/19/2018 CAN (ON): Peter Quiring to build 1.4 million sq.ft. MJ greenhouse
6/15/2018 SoCal MJ industry plagued by tax and pesticide woes
6/13/2018 Inside Britain's biggest weed greenhouse
6/13/2018 Aurora Cannabis to acquire Anandia Laboratories
6/13/2018 CAN (ON): WeedMD secures licence for large-scale MJ greenhouse
6/12/2018 Canada: Deloitte expects cannabis sales to exceed $7 billion
6/7/2018 Canada prepares to make marijuana legal
6/6/2018 CAN (QC): MYM finalizes purchase of 329 acres of land in Weedon
6/6/2018 US (OH): Integrating LED to address impending MMJ demand
6/5/2018 Macedonia: MMJ grower expands cultivation under LED
6/1/2018 US (MA): Sale of orchard for MJ greenhouse on hold amid public outcry
5/31/2018 CAN (BC): Harvest One expands at Aldergrove site
5/30/2018 CAN (BC): Emerald Health commences production at Delta 3 site
5/30/2018 CAN (QC): MYM hires Casey Houweling for 1.5 million sq.ft. project
5/29/2018 US (WA): LED lighting increases quality at pesticide-free cultivation facility
5/29/2018 US (FL): Ban on smokable medical marijuana 'unconstitutional'